Cost of multidrug resistant tuberculosis in Germany—An update

Cost of multidrug resistant tuberculosis in Germany—An update

Background: In 2019, new therapeutic recommendations for multidrug-resistant (MDR-) and extensively drug-resistant (XDR) tuberculosis (TB) were published by the WHO, advocating the use of oral drugs and stepwise composition of antibiotic regimens. To date, the economic consequences of those recommen...

Full description

Bibliographic Details
Main Authors:	R. Diel, G. Sotgiu, S. Andres, D. Hillemann, F.P. Maurer
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Series:	International Journal of Infectious Diseases
Subjects:	Cost analysis Monte Carlo simulation Tuberculosis MDR-TB XDR-TB Antimicrobial resistance
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220322876

Similar Items

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

Trends in multidrug-resistant tuberculosis
by: I. M. F. Dias-Baptista, et al.
Published: (2008-01-01)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016-06-01)

Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
by: Jay Achar, et al.
Published: (2017-10-01)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)

A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
by: Parul Singhal, et al.
Published: (2016-01-01)

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
by: Jaksuwan R, et al.
Published: (2017-06-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan
by: Yoshiro Murase, et al.
Published: (2010-06-01)

Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa
by: Said Halima M, et al.
Published: (2012-12-01)

Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
by: Jun Chen, et al.
Published: (2017-04-01)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
by: Mahdieh Sayadi, et al.
Published: (2020-06-01)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
by: Giovanni Battista Migliori, et al.
Published: (2017-02-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)

Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
by: Stefan Panaiotov, et al.
Published: (2014-11-01)

Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009–2010
by: Vladimir Milanov, et al.
Published: (2015-01-01)

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
by: Ximena Gonzalo, et al.
Published: (2020-08-01)

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
by: Kristina Wallengren, et al.
Published: (2011-10-01)

Investigation of Susceptibility of Mycobacterium tuberculosis Complex Strains Isolated from Clinical Samples Against the First and Second-Line Anti-tuberculosis Drugs by the Sensititre MycoTB Plate Method
by: Figen KAYSERİLİ ORHAN, et al.
Published: (2018-03-01)

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia
by: Sergo Vashakidze, et al.
Published: (2017-03-01)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
by: R Prasad
Published: (2012-01-01)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
by: Giovanni Sotgiu, et al.
Published: (2016-03-01)

Drug-resistant tuberculosis: an experience from Qatar
by: Maisa Ali, et al.
Published: (2020-01-01)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
by: Gunar Günther, et al.
Published: (2015-03-01)

Drug-Resistant Tuberculosis, Lebanon, 2016 – 2017
by: Salam El Achkar, et al.
Published: (2019-03-01)

Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): A retrospective record-based study
by: Nandini Sharma, et al.
Published: (2020-01-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data
by: Wouter Deelder, et al.
Published: (2019-09-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)

Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01)

Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory
by: Azger Dusthackeer, et al.
Published: (2015-01-01)

Factors associated with multidrug-resistant tuberculosis
by: Md Nurul Amin, et al.
Published: (2009-01-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
by: Xiaocui Wu, et al.
Published: (2019-11-01)

atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
by: Aubry, A., et al.
Published: (2022)

TUBERCULOSIS WITH CONCURRENT HIV INFECTION IN RUSSIA: STATISTICS AND CORRELATIONS
by: E. B. Tsybikova, et al.
Published: (2019-01-01)